Listed

Benitec Biopharma Inc.

BNTCNasdaqCIK 1808898HealthcareFiscal year ends Dec 31

Reports and events: 136 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Benitec Biopharma Inc., Reports and events
FiledFormWhat it isAccession number
2022-09-0208:04 ET10-KAnnual reportPeriod 2022-06-300001193125-22-237075
2022-09-0208:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-237060
2022-08-1015:39 ETS-1/ARegistration statement, amended0001193125-22-217292
2022-08-0808:57 ETS-1/ARegistration statement, amended0001193125-22-214263
2022-07-2916:36 ETS-1Registration statement0001193125-22-206703
2022-05-1608:01 ET10-QQuarterly reportPeriod 2022-03-310001193125-22-150924
2022-05-1608:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-150922
2022-02-1408:19 ET10-QQuarterly reportPeriod 2021-12-310001193125-22-039683
2022-02-1408:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-039653
2022-01-2116:31 ET8-K/A5.07 Shareholder vote results0001193125-22-014852
2021-12-2116:31 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-21-363633
2021-12-1317:16 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-21-355561
2021-11-1509:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-329092
2021-11-1506:10 ET10-QQuarterly reportPeriod 2021-09-300001193125-21-328795
2021-10-2206:05 ETDEF 14AProxy statementPeriod 2021-12-080001193125-21-304643
2021-09-2008:15 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-276778
2021-09-2008:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-276763
2021-09-2008:00 ET10-KAnnual reportPeriod 2021-06-300001193125-21-276758
2021-05-1217:12 ET10-QQuarterly reportPeriod 2021-03-310001193125-21-159276
2021-04-2917:05 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-140764
2021-02-2417:26 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-054896
2021-02-0906:35 ET10-QQuarterly reportPeriod 2020-12-310001193125-21-033243
2020-12-1516:59 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-20-318182
2020-12-1417:16 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-20-317105
2020-11-1306:31 ET10-QQuarterly reportPeriod 2020-09-300001193125-20-292209
2020-11-0317:00 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001193125-20-284828
2020-10-2716:05 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-278391
2020-10-2216:43 ETDEF 14AProxy statementPeriod 2020-12-090001193125-20-274452
2020-10-0616:45 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-264805
2020-10-0109:34 ETS-1/ARegistration statement, amended0001193125-20-260736
2020-09-2317:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-252398
2020-09-2316:50 ET10-KAnnual reportPeriod 2020-06-300001193125-20-252381
2020-08-1916:15 ET8-K/A4.01 Change of auditor; 9.01 Financial statements and exhibits0001193125-20-224708
2020-08-1819:14 ET8-K8.01 Other events0001193125-20-222612
2020-08-1416:11 ETS-1Registration statement0001193125-20-220358
2020-06-0517:25 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001193125-20-162330

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:28 ET. Listed shows no prices and gives no investment advice.